Driven by patients,
guided by science and
powered by your donations
Cancer patients deserve optimal treatment. We are supporting scientific research and outstanding care for cancer patients.
The Anticancer Fund is a Belgian non-profit organisation with an international scope. We depend fully on donations and private funding to finance our work.
We believe in the power of science to find solutions for cancer patients.
We also believe that science should be accessible to all – making information available to researchers and patients alike is part of how we work.
We invest in the most promising research to make measurable progress in the fight against cancer.
We strive to improve survival and quality of life, financial return is not within the scope of our activities.
We identify untapped potential in cancer research leading to pragmatic solutions for patients in need.
We seek impact and we invest our resources where we believe we can make the most progress.
Every cancer deserves the same attention, regardless of prevalence or profitability.
In the news
Are repurposed drugs ready for use in cancer?
What about vaccines against cancer?
Experimental therapies: 50 shades of grey
Honorary Nomination at UCL London
DIPG is one of the deadliest forms of childhood cancer
WE MAKE A DIFFERENCE
We invest in researchWe put science to work for patients and we strive for short-term, meaningful impacts where they are most needed.
We set up clinical trialsWe are an independent, non-profit intermediary and focus on clinical research with limited economic value.
We connect peopleAs we are just a small part of the enormous cancer research ecosystem, we don't act alone.
We advise professionalsAccording to our mission and vision, we provide free advice in designing trials and reviewing scientific research.
We help cancer patientsWe personally answer therapy-related questions from patients and provide non-judgmental information.
Our current focus areas
Drug repurposingDrug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse of existing...
Less common and rare cancersWe don’t just focus on the ‘big four’ of cancer – prostate, colon, breast and lung. We also investigate new treatment...
Combination therapiesIt is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in combination...
Preventing tumour recurrenceFor cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living...